NCT06623487View on ClinicalTrials.gov

The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2027

Conditions

Carcinoma, Non-Small-Cell LungPET / CTNeoadjuvant Immunotherapy

Trial Locations (1)

200000

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors

lead

Ruijin Hospital

OTHER